23rd Apr 2025 Plain language summary of a review on omalizumab for treating chronic spontaneous urticaria
22nd Jan 2024 Two different concentrations of GP2017 (a biosimilar medicine) are associated with similar drug levels in the body- a plain language summary
2nd Jun 2023 Plain Language Summary: comparing how well abrocitinib and dupilumab treat atopic dermatitis signs and symptoms